Skip to Content

TL 383 TL 383 (Terazosin 1 mg)

Pill with imprint TL 383 TL 383 is Gray, Capsule-shape and has been identified as Terazosin hydrochloride 1 mg. It is supplied by Cadista.

Terazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; hyperhidrosis and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Terazosin 1 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for TL 383 TL 383

Terazosin hydrochloride

Imprint:
TL 383 TL 383
Strength:
1 mg
Color:
Gray
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antiadrenergic agents, peripherally acting
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Cadista
Inactive Ingredients:
ferrosoferric oxide
gelatin
lactose monohydrate
magnesium stearate
sodium lauryl sulfate
titanium dioxide
corn starch
silicon dioxide
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
67544-0581 Prepak Systems Inc (repackager)

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide